Guardant Health: Pay

Guardant Health paid its 4 named executives $17.0M in total in FY2023 (Dec).

Pay of each named executive

FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
3 years
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
3 years
FY2021 (Dec)Not disclosed
1 year
FY2021 (Dec)Not disclosed
1 year

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 6 peers with pay on file was $11.7M. CEO pay of Guardant Health for that year is not on file.

  1. 1Exelixis
  2. 2Natera
  3. 3GLAUKOS
  4. 4Ultragenyx Pharmaceutical
  5. 5Repligen
  6. 6Penumbra
  7. 7Guardant HealthNot disclosed
  8. 810x Genomics, Inc.Not disclosed
  9. 9ACADIA Pharmaceuticals Inc.Not disclosed
  10. 10Blueprint Medicines CorporationNot disclosed
  11. 11Exact Sciences CorporationNot disclosed
  12. 12Lantheus HoldingsNot disclosed
  13. 13Myriad Genetics, Inc.Not disclosed
  14. 14NeoGenomics, Inc.Not disclosed
  15. 15Novocure Ltd.Not disclosed
  16. 16Twist Bioscience CorporationNot disclosed
  17. 17Veracyte, Inc.Not disclosed
  18. 18iRythym Technologies, Inc.Not disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.